Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep
Authors:
- M. AlvinerieMAM. Alvinerie
- T. PineauTPT. Pineau
- C. BoulardCBC. Boulard
- P. GaltierPGP. Galtier
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 18 (4) , 357-364
Abstract
The pharmacokinetics of i.v. antipyrine (25 mg/kg) used as a model compound, were determined in young male sheep, before and each month after an oral infestation by 150 metacercariae of Fasciola hepatica and 8 weeks following a flukicidal treatment. The parasitic pathology was ascertained by the clinical observation of animals and the increase in plasma antibodies directed against liver flukes. A significant decrease in the total plasma clearance of the drug occurred by week 4 to 16, and a 1.7 fold increase in mean residence time occurred by week 12 post-infection. Urinary excretion of antipyrine metabolites was determined before and 8 weeks following the infestation. 4-Hydroxyantipyrine was the major urinary metabolite and its excretion was decreased by 30% in infected sheep, whereas there was no change in the excretion of norantipyrine, 3-hydroxymethylantipyrine or unmetabolized drug. It is concluded that the impairment of antipyrine clearance in the course of fascioliasis could be related to the decrease in liver microsomal cytochrome P-450-dependent mono-oxygenases observed in sheep with a similar parasitic burden.Keywords
This publication has 21 references indexed in Scilit:
- Characterization of the microsomal cytochrome P-450 species inhibited in rat liver in the course of fascioliasisBiochemical Pharmacology, 1986
- Studies on rat liver cytochrome P-450s involved in the metabolism of antipyrine: phenobarbital- and 3-methylcholanthrene-inducible isozymes possessing 4-hydroxylase activityBiochemical Pharmacology, 1986
- Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian speciesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1984
- Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative ParadigmDrug Metabolism Reviews, 1984
- Interindividual Variations in Drug DispositionClinical Pharmacokinetics, 1983
- Pharmacokinetics1982
- Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymesClinical Pharmacology & Therapeutics, 1979
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979
- Biochemical indicators of liver injury in calves with experimental fascioliasisVeterinary Record, 1977